vs
亚什兰（ASH）与Claritev Corp（CTEV）财务数据对比。点击上方公司名可切换其他公司
亚什兰的季度营收约是Claritev Corp的1.6倍（$386.0M vs $246.6M），亚什兰净利率更高（-3.1% vs -32.7%，领先29.6%），Claritev Corp同比增速更快（6.2% vs -4.7%），亚什兰自由现金流更多（$111.0M vs $36.4M），过去两年Claritev Corp的营收复合增速更高（2.5% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
ASH vs CTEV — 直观对比
营收规模更大
ASH
是对方的1.6倍
$246.6M
营收增速更快
CTEV
高出10.9%
-4.7%
净利率更高
ASH
高出29.6%
-32.7%
自由现金流更多
ASH
多$74.6M
$36.4M
两年增速更快
CTEV
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $246.6M |
| 净利润 | $-12.0M | $-80.6M |
| 毛利率 | 27.2% | — |
| 营业利润率 | -1.6% | -3.1% |
| 净利率 | -3.1% | -32.7% |
| 营收同比 | -4.7% | 6.2% |
| 净利润同比 | 92.7% | 41.6% |
| 每股收益（稀释后） | $-0.26 | $-4.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHCTEV
| Q4 25 | $386.0M | $246.6M | ||
| Q3 25 | $477.0M | $246.0M | ||
| Q2 25 | $463.0M | $241.6M | ||
| Q1 25 | $479.0M | $231.3M | ||
| Q4 24 | $405.0M | $232.1M | ||
| Q3 24 | $521.0M | $230.5M | ||
| Q2 24 | $544.0M | $233.5M | ||
| Q1 24 | $575.0M | $234.5M |
净利润ASHCTEV
| Q4 25 | $-12.0M | $-80.6M | ||
| Q3 25 | $31.0M | $-69.8M | ||
| Q2 25 | $-742.0M | $-62.6M | ||
| Q1 25 | $31.0M | $-71.3M | ||
| Q4 24 | $-165.0M | $-138.0M | ||
| Q3 24 | $17.0M | $-391.4M | ||
| Q2 24 | $6.0M | $-576.7M | ||
| Q1 24 | $120.0M | $-539.7M |
毛利率ASHCTEV
| Q4 25 | 27.2% | — | ||
| Q3 25 | 33.3% | — | ||
| Q2 25 | 28.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 27.4% | — | ||
| Q3 24 | 33.2% | — | ||
| Q2 24 | 34.2% | — | ||
| Q1 24 | 28.0% | — |
营业利润率ASHCTEV
| Q4 25 | -1.6% | -3.1% | ||
| Q3 25 | 12.8% | 4.1% | ||
| Q2 25 | -152.9% | 6.9% | ||
| Q1 25 | 10.6% | 4.2% | ||
| Q4 24 | -44.2% | -17.8% | ||
| Q3 24 | 6.1% | -146.7% | ||
| Q2 24 | -11.2% | -224.4% | ||
| Q1 24 | 3.7% | -207.4% |
净利率ASHCTEV
| Q4 25 | -3.1% | -32.7% | ||
| Q3 25 | 6.5% | -28.4% | ||
| Q2 25 | -160.3% | -25.9% | ||
| Q1 25 | 6.5% | -30.8% | ||
| Q4 24 | -40.7% | -59.4% | ||
| Q3 24 | 3.3% | -169.8% | ||
| Q2 24 | 1.1% | -247.0% | ||
| Q1 24 | 20.9% | -230.1% |
每股收益（稀释后）ASHCTEV
| Q4 25 | $-0.26 | $-4.88 | ||
| Q3 25 | $0.83 | $-4.23 | ||
| Q2 25 | $-16.21 | $-3.81 | ||
| Q1 25 | $0.65 | $-4.38 | ||
| Q4 24 | $-3.50 | $-8.49 | ||
| Q3 24 | $0.34 | $-24.25 | ||
| Q2 24 | $0.12 | $-35.78 | ||
| Q1 24 | $2.39 | $-33.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $16.8M |
| 总债务越低越好 | $1.4B | $4.6B |
| 股东权益账面价值 | $1.9B | $-173.9M |
| 总资产 | $4.5B | $4.9B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHCTEV
| Q4 25 | $304.0M | $16.8M | ||
| Q3 25 | $215.0M | $39.2M | ||
| Q2 25 | $207.0M | $56.4M | ||
| Q1 25 | $168.0M | $23.1M | ||
| Q4 24 | $219.0M | $16.8M | ||
| Q3 24 | $300.0M | $86.6M | ||
| Q2 24 | $399.0M | $48.8M | ||
| Q1 24 | $439.0M | $58.7M |
总债务ASHCTEV
| Q4 25 | $1.4B | $4.6B | ||
| Q3 25 | $1.4B | $4.5B | ||
| Q2 25 | $1.4B | $4.5B | ||
| Q1 25 | $1.3B | $4.5B | ||
| Q4 24 | $1.3B | $4.5B | ||
| Q3 24 | $1.3B | $4.5B | ||
| Q2 24 | $1.3B | $4.5B | ||
| Q1 24 | $1.3B | $4.5B |
股东权益ASHCTEV
| Q4 25 | $1.9B | $-173.9M | ||
| Q3 25 | $1.9B | $-101.8M | ||
| Q2 25 | $1.9B | $-39.9M | ||
| Q1 25 | $2.6B | $14.8M | ||
| Q4 24 | $2.6B | $84.0M | ||
| Q3 24 | $2.9B | $207.6M | ||
| Q2 24 | $3.0B | $603.4M | ||
| Q1 24 | $3.1B | $1.2B |
总资产ASHCTEV
| Q4 25 | $4.5B | $4.9B | ||
| Q3 25 | $4.6B | $5.0B | ||
| Q2 25 | $4.6B | $5.1B | ||
| Q1 25 | $5.2B | $5.1B | ||
| Q4 24 | $5.2B | $5.2B | ||
| Q3 24 | $5.6B | $5.3B | ||
| Q2 24 | $5.7B | $5.7B | ||
| Q1 24 | $5.9B | $6.4B |
负债/权益比ASHCTEV
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | 304.87× | ||
| Q4 24 | 0.51× | 53.67× | ||
| Q3 24 | 0.47× | 21.73× | ||
| Q2 24 | 0.45× | 7.48× | ||
| Q1 24 | 0.42× | 3.85× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $66.3M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $36.4M |
| 自由现金流率自由现金流/营收 | 28.8% | 14.8% |
| 资本支出强度资本支出/营收 | 3.6% | 12.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | $-12.3M |
8季度趋势，按日历期对齐
经营现金流ASHCTEV
| Q4 25 | $125.0M | $66.3M | ||
| Q3 25 | $40.0M | $19.9M | ||
| Q2 25 | $115.0M | $61.2M | ||
| Q1 25 | $9.0M | $-30.1M | ||
| Q4 24 | $-30.0M | $-33.4M | ||
| Q3 24 | $80.0M | $72.8M | ||
| Q2 24 | $127.0M | $18.5M | ||
| Q1 24 | $54.0M | $49.7M |
自由现金流ASHCTEV
| Q4 25 | $111.0M | $36.4M | ||
| Q3 25 | $6.0M | $-16.3M | ||
| Q2 25 | $95.0M | $36.6M | ||
| Q1 25 | $-12.0M | $-68.9M | ||
| Q4 24 | $-53.0M | $-63.8M | ||
| Q3 24 | $42.0M | $41.1M | ||
| Q2 24 | $98.0M | $-7.0M | ||
| Q1 24 | $20.0M | $19.2M |
自由现金流率ASHCTEV
| Q4 25 | 28.8% | 14.8% | ||
| Q3 25 | 1.3% | -6.6% | ||
| Q2 25 | 20.5% | 15.2% | ||
| Q1 25 | -2.5% | -29.8% | ||
| Q4 24 | -13.1% | -27.5% | ||
| Q3 24 | 8.1% | 17.8% | ||
| Q2 24 | 18.0% | -3.0% | ||
| Q1 24 | 3.5% | 8.2% |
资本支出强度ASHCTEV
| Q4 25 | 3.6% | 12.1% | ||
| Q3 25 | 7.1% | 14.7% | ||
| Q2 25 | 4.3% | 10.2% | ||
| Q1 25 | 4.4% | 16.8% | ||
| Q4 24 | 5.7% | 13.1% | ||
| Q3 24 | 7.3% | 13.8% | ||
| Q2 24 | 5.3% | 10.9% | ||
| Q1 24 | 5.9% | 13.0% |
现金转化率ASHCTEV
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | — | ||
| Q2 24 | 21.17× | — | ||
| Q1 24 | 0.45× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
CTEV
暂无分部数据
